Xin Yu

Xin (Jack) Yu is an accomplished professional in the field of analytical development, currently serving as Vice President of Analytical Development at Moderna since July 2023. Prior to this role, Xin held various leadership positions at Alexion, AstraZeneca Rare Disease, including Executive Director and Interim Head of Analytical Development and Clinical QC, where responsibilities encompassed biological and synthetic analytical development, protein characterization, and clinical quality control. Xin's career began at Merck as an Associate Principal Scientist and Senior Scientist, focusing on characterization and method development. Academic credentials include a Ph.D. in Analytical Chemistry from the University of Connecticut, complemented by research experience as a Postdoctoral Associate at Tufts University and as a Graduate Research Assistant at the University of Connecticut.